In asthma, exacerbations and poor disease control are linked to airway allergic inflammation. Serum periostin has been proposed as a systemic biomarker of eosinophilic inflammation. This pilot study aims at evaluating whether in patients with moderate asthma, higher baseline levels of serum periostin are associated with a greater risk of exacerbation.

Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics

Crimi, C;Iemmolo, M;Crimi, N
2016-01-01

Abstract

In asthma, exacerbations and poor disease control are linked to airway allergic inflammation. Serum periostin has been proposed as a systemic biomarker of eosinophilic inflammation. This pilot study aims at evaluating whether in patients with moderate asthma, higher baseline levels of serum periostin are associated with a greater risk of exacerbation.
2016
Airway inflammation; Asthma; Exacerbation; Periostin; Serum biomarker
File in questo prodotto:
File Dimensione Formato  
Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Dimensione 456.62 kB
Formato Adobe PDF
456.62 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/318712
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact